- [Home](/) ›
- [ClinicalTrialStartPulse](/v/clinicaltrialstartpulse) ›
- [Hubs](/hub/clinicaltrialstartpulse) ›
- [All record reports](/hub/clinicaltrialstartpulse/records) ›
- Page 2

# ClinicalTrialStartPulse: all 1,000 record reports, page 2 of 5

Every ClinicalTrialStartPulse record report, 200 per page, grouped by state. Records 201 to 400: Fujian Medical University Union Hospital: Observational study in Dementia, Alzheimer Dementia (AD) (3000 participants) to Peking Union Medical College Hospital: Observational study in Glycogen Storage Disease (318 participants). Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2.

[1](/hub/clinicaltrialstartpulse/records) 2 [3](/hub/clinicaltrialstartpulse/records/3) [4](/hub/clinicaltrialstartpulse/records/4) [5](/hub/clinicaltrialstartpulse/records/5)

## NONUS

- [Fujian Medical University Union Hospital: Observational study in Dementia, Alzheimer Dementia (AD) (3000 participants)](/report/clinicaltrialstartpulse/fujian-medical-university-union-hospital-nonus--nct-nct07891429)
- [Fujian Medical University Union Hospital: Phase 3 study in Acute Ischemic Stroke, Large Vessel Occlusion (1266 participants)](/report/clinicaltrialstartpulse/fujian-medical-university-union-hospital-nonus--nct-nct07912970)
- [Fundació d'investigació Sanitària de les Illes Balears: Phase 3 study in Traumatic Brain Injury (TBI) Patients (536 participants)](/report/clinicaltrialstartpulse/fundacio-d-investigacio-sanitaria-de-les-illes-balears-nonus--nct-nct07899164)
- [Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau: Not applicable (device, behavioral) study in Falls, Ulcer, Pressure (530 participants)](/report/clinicaltrialstartpulse/fundacio-institut-de-recerca-de-l-hospital-de-la-santa-creu-nonus--nct-nct07890688)
- [Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau: Phase 3 study in Acute Ischemic Stroke, Large Vessel Occlusion (314 participants)](/report/clinicaltrialstartpulse/fundacio-institut-de-recerca-de-l-hospital-de-la-santa-creu-nonus--nct-nct07902791)
- [Fundación Santa Fe de Bogota: Observational study in Breast Neoplasms, Triple Negative Breast Neoplasms (370 participants)](/report/clinicaltrialstartpulse/fundacion-santa-fe-de-bogota-nonus--nct-nct07856225)
- [Fundación Santa Fe de Bogota: Observational study in Overactive Bladder (OAB), Urgency Urinary Incontinence (1700 participants)](/report/clinicaltrialstartpulse/fundacion-santa-fe-de-bogota-nonus--nct-nct07856238)
- [Fundación Santa Fe de Bogota: Observational study in Pain Management, C Section (336 participants)](/report/clinicaltrialstartpulse/fundacion-santa-fe-de-bogota-nonus--nct-nct07859956)
- [Galderma R&D: Not applicable (device, behavioral) study in Cheek Wrinkles, Midface Contour Deficiencies (326 participants)](/report/clinicaltrialstartpulse/galderma-r-and-d-nonus--nct-nct07909421)
- [GC Biopharma Corp: Phase 3 study in Influenza A, Influenza B, Influenza Vaccination (1806 participants)](/report/clinicaltrialstartpulse/gc-biopharma-corp-nonus--nct-nct07883928)
- [GCS Ramsay Santé pour l'Enseignement et la Recherche: Not applicable (device, behavioral) study in Chronic Kidney Diseases (312 participants)](/report/clinicaltrialstartpulse/gcs-ramsay-sante-pour-l-enseignement-et-la-recherche-nonus--nct-nct07869849)
- [GCS Ramsay Santé pour l'Enseignement et la Recherche: Observational study in Exposome, Non-communicable Diseases (NCD) (2500 participants)](/report/clinicaltrialstartpulse/gcs-ramsay-sante-pour-l-enseignement-et-la-recherche-nonus--nct-nct07879378)
- [Genentech, Inc.: Phase 1 study in Colorectal Neoplasms, Pancreatic Ductal Adenocarcinoma (388 participants)](/report/clinicaltrialstartpulse/genentech-inc-nonus--nct-nct07859085)
- [General Hospital of Ningxia Medical University: Observational study in Emergence Delirium in Pediatric Anesthesia (470 participants)](/report/clinicaltrialstartpulse/general-hospital-of-ningxia-medical-university-nonus--nct-nct07906977)
- [Genfleet Therapeutics (Shanghai) Inc.: Phase 3 study in Colorectal Cancer (368 participants)](/report/clinicaltrialstartpulse/genfleet-therapeutics-shanghai-inc-nonus--nct-nct07913360)
- [Genmab: Phase 3 study in Ovarian Cancer (602 participants)](/report/clinicaltrialstartpulse/genmab-nonus--nct-nct07859215)
- [Genoss Co., Ltd.: Not applicable (device, behavioral) study started recruiting, 892 planned (Multi Vessel Coronary Artery Disease, Percutaneous Coronary Intervention)](/report/clinicaltrialstartpulse/genoss-co-ltd-nonus--nct-nct07539324-recruiting)
- [George Washington University: Observational study closed enrollment, 1441 enrolled (Type 1 Diabetes Mellitus)](/report/clinicaltrialstartpulse/george-washington-university-nonus--nct-nct00360893-enrollment)
- [German Cancer Research Center: Phase 3 study in Non-Small Cell Lung Cancer (406 participants)](/report/clinicaltrialstartpulse/german-cancer-research-center-nonus--nct-nct07877584)
- [Germans Trias i Pujol Hospital: Observational study in Retinal Artery Occlusion, Central Retinal Artery Occlusion (500 participants)](/report/clinicaltrialstartpulse/germans-trias-i-pujol-hospital-nonus--nct-nct07900230)
- [Gérond'if: Observational study started recruiting, 5900 planned (Viral Pulmonary Infections)](/report/clinicaltrialstartpulse/gerond-if-nonus--nct-nct07539103-recruiting)
- [GIFT University: Not applicable (device, behavioral) study in Hypertension, Primary Hypertension (1295 participants)](/report/clinicaltrialstartpulse/gift-university-nonus--nct-nct07878728)
- [GlaxoSmithKline: Phase 3 study in Cardiovascular Disease (16390 participants)](/report/clinicaltrialstartpulse/glaxosmithkline-nonus--nct-nct07872046)
- [GlaxoSmithKline: Phase 3 study in Endometrial Carcinoma, Neoplasms, Endometrial (378 participants)](/report/clinicaltrialstartpulse/glaxosmithkline-nonus--nct-nct07860450)
- [GlaxoSmithKline: Phase 3 study started recruiting, 610 planned (Neoplasms, Endometrial)](/report/clinicaltrialstartpulse/glaxosmithkline-nonus--nct-nct07684599-recruiting)
- [GlaxoSmithKline: Phase 3 study started recruiting, 720 planned (Ovarian Neoplasms)](/report/clinicaltrialstartpulse/glaxosmithkline-nonus--nct-nct07694427-recruiting)
- [Global Institute of Human Development: Not applicable (device, behavioral) study closed enrollment, 600 enrolled (Depression Anxiety Disorder, Psychological Distress)](/report/clinicaltrialstartpulse/global-institute-of-human-development-nonus--nct-nct07399314-enrollment)
- [Government Super Speciality Hospital, Shireen Bagh, Srinagar: Observational study in Kidney Calculi (or Renal Calculi / Nephrolithiasis), Renal Calculi (688 participants)](/report/clinicaltrialstartpulse/government-super-speciality-hospital-shireen-bagh-srinagar-nonus--nct-nct07906964)
- [Groupe Oncologie Radiotherapie Tete et Cou: Phase 3 study closed enrollment, 680 enrolled (Squamous Cell Carcinoma of Head and Neck)](/report/clinicaltrialstartpulse/groupe-oncologie-radiotherapie-tete-et-cou-nonus--nct-nct03576417-enrollment)
- [Groupe Oncologie Radiotherapie Tete et Cou: Phase 3 study closed enrollment, 707 enrolled (HNSCC)](/report/clinicaltrialstartpulse/groupe-oncologie-radiotherapie-tete-et-cou-nonus--nct-nct02999087-enrollment)
- [Guangdong Second Provincial General Hospital: Not applicable (device, behavioral) study in Acute Ischemic Stroke, Basilar Artery Occlusion (818 participants)](/report/clinicaltrialstartpulse/guangdong-second-provincial-general-hospital-nonus--nct-nct07896655)
- [Guangzhou Institute of Respiratory Disease: Observational study in Chronic Obstructive Pulmonary Disease (COPD), Traditional Chinese Medicine Syndrome (400 participants)](/report/clinicaltrialstartpulse/guangzhou-institute-of-respiratory-disease-nonus--nct-nct07873489)
- [Guangzhou Patronus Biotech Co., Ltd.: Phase 3 study in Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection (25000 participants)](/report/clinicaltrialstartpulse/guangzhou-patronus-biotech-co-ltd-nonus--nct-nct07908654)
- [Guangzhou University of Chinese Medicine: Not applicable (device, behavioral) study completed, 542 enrolled (Airway Management, General Anesthesia)](/report/clinicaltrialstartpulse/guangzhou-university-of-chinese-medicine-nonus--nct-nct07699653-completed)
- [Guizhou Provincial People's Hospital: Observational study in Endometrial Cancer, Atypical Endometrial Hyperplasia (512 participants)](/report/clinicaltrialstartpulse/guizhou-provincial-people-s-hospital-nonus--nct-nct07892755)
- [Gustave Roussy, Cancer Campus, Grand Paris: Phase 3 study in Osteosarcoma, Pediatric Osteosarcoma (530 participants)](/report/clinicaltrialstartpulse/gustave-roussy-cancer-campus-grand-paris-nonus--nct-nct07871864)
- [Guttmacher Institute: Not applicable (device, behavioral) study in Contraceptive Behavior, Self Administration (2736 participants)](/report/clinicaltrialstartpulse/guttmacher-institute-nonus--nct-nct07888296)
- [Guttmacher Institute: Not applicable (device, behavioral) study in Contraceptive Behavior, Social Norms (5436 participants)](/report/clinicaltrialstartpulse/guttmacher-institute-nonus--nct-nct07902700)
- [Guttmacher Institute: Not applicable (device, behavioral) study in Reproductive Health, Sexual Health (5300 participants)](/report/clinicaltrialstartpulse/guttmacher-institute-nonus--nct-nct07860723)
- [Guy's and St Thomas' NHS Foundation Trust: Observational study in Acute Kidney Injury (630 participants)](/report/clinicaltrialstartpulse/guy-s-and-st-thomas-nhs-foundation-trust-nonus--nct-nct07903519)
- [HALEON: Observational study in Pain (2100 participants)](/report/clinicaltrialstartpulse/haleon-nonus--nct-nct07909590)
- [Hamad Medical Corporation: Observational study in Hematological Malignancy, Hematopoetic Stem Cell Transplantation (1000 participants)](/report/clinicaltrialstartpulse/hamad-medical-corporation-nonus--nct-nct07900542)
- [Hamad Medical Corporation: Phase 4 study in Oligoasthenoteratozoospermia, Male Infertility (360 participants)](/report/clinicaltrialstartpulse/hamad-medical-corporation-nonus--nct-nct07862725)
- [Hansoh BioMedical R&D Company: Phase 1 study in Extensive Stage Small Cell Lung Cancer (ES-SCLC) (338 participants)](/report/clinicaltrialstartpulse/hansoh-biomedical-r-and-d-company-nonus--nct-nct07892625)
- [Hansoh BioMedical R&D Company: Phase 2 study in Moderate-to-severe Plaque Psoriasis (390 participants)](/report/clinicaltrialstartpulse/hansoh-biomedical-r-and-d-company-nonus--nct-nct07879885)
- [Harding Center for Risk Literacy: Not applicable (device, behavioral) study started recruiting, 330 planned (Shared Decision Making, Health Literacy)](/report/clinicaltrialstartpulse/harding-center-for-risk-literacy-nonus--nct-nct07827924-recruiting)
- [Harvard School of Public Health (HSPH): Not applicable (device, behavioral) study completed, 968 enrolled (Cardiovascular Diseases (CVD))](/report/clinicaltrialstartpulse/harvard-school-of-public-health-hsph-nonus--nct-nct05511701-completed)
- [Hawler Medical University: Not applicable (device, behavioral) study completed, 1248 enrolled (Morbid Obesity)](/report/clinicaltrialstartpulse/hawler-medical-university-nonus--nct-nct05569681-completed)
- [Heart Health Research Center: Not applicable (device, behavioral) study in Heart Failure, Influenza Vaccination (588 participants)](/report/clinicaltrialstartpulse/heart-health-research-center-nonus--nct-nct07880158)
- [Hellenic Cooperative Oncology Group: Observational study closed enrollment, 750 enrolled (Breast Cancer)](/report/clinicaltrialstartpulse/hellenic-cooperative-oncology-group-nonus--nct-nct04403984-enrollment)
- [Hellenic Cooperative Oncology Group: Observational study in ESR1 Gene Mutation, Breast Cancer (Locally Advanced or Metastatic) (500 participants)](/report/clinicaltrialstartpulse/hellenic-cooperative-oncology-group-nonus--nct-nct07899463)
- [Hellenic Institute for the Study of Sepsis: Phase 3 study started recruiting, 398 planned (Sepsis)](/report/clinicaltrialstartpulse/hellenic-institute-for-the-study-of-sepsis-nonus--nct-nct07813767-recruiting)
- [Helse Nord-Trøndelag HF: Not applicable (device, behavioral) study in Smoking Cessation, Smoking Cessation Counselling (620 participants)](/report/clinicaltrialstartpulse/helse-nord-tr-ndelag-hf-nonus--nct-nct07900724)
- [Hinova Pharmaceuticals Inc.: Phase 3 study in High Risk Biochemical Recurrence (BCR), Deutenzalutamide Soft Capsules (1044 participants)](/report/clinicaltrialstartpulse/hinova-pharmaceuticals-inc-nonus--nct-nct07875881)
- [Hoffmann-La Roche: Observational study started recruiting, 1800 planned (Relapsing-Remitting Multiple Sclerosis)](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct07827586-recruiting)
- [Hoffmann-La Roche: Phase 1 study in Locally Advanced or Metastatic Solid Tumors (405 participants)](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct07883577)
- [Hoffmann-La Roche: Phase 1 study in Solid Tumors (540 participants)](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct07905924)
- [Hoffmann-La Roche: Phase 3 study closed enrollment, 342 enrolled (Hepatocellular Carcinoma)](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct04712643-enrollment)
- [Hoffmann-La Roche: Phase 3 study closed enrollment, 451 enrolled (Neovascular Age-related Macular Degeneration (nAMD))](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct04657289-enrollment)
- [Hoffmann-La Roche: Phase 3 study in Type 2 Diabetes Mellitus (948 participants)](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct07889648)
- [Hoffmann-La Roche: Phase 3 study started recruiting, 325 planned (Influenza, Human, Respiratory Tract Infections)](/report/clinicaltrialstartpulse/hoffmann-la-roche-nonus--nct-nct07827599-recruiting)
- [Hospital Clinico Universitario de Santiago: Not applicable (device, behavioral) study completed, 1036 enrolled (Acute Respiratory Failure, Intubation)](/report/clinicaltrialstartpulse/hospital-clinico-universitario-de-santiago-nonus--nct-nct06322719-completed)
- [Hospital del Rio Hortega: Observational study in Hip Fracture (829 participants)](/report/clinicaltrialstartpulse/hospital-del-rio-hortega-nonus--nct-nct07908836)
- [Hospital Dr Sotero del Rio: Not applicable (device, behavioral) study in Borderline Personality Disorder (BPD), Dialectical Behavior Therapy (360 participants)](/report/clinicaltrialstartpulse/hospital-dr-sotero-del-rio-nonus--nct-nct07875166)
- [Hospital Universitario La Paz: Observational study in Hepatocellular Carcinoma (HCC) (417 participants)](/report/clinicaltrialstartpulse/hospital-universitario-la-paz-nonus--nct-nct07872319)
- [Hospital Universitario Ramon y Cajal: Not applicable (device, behavioral) study in Kidney Transplantation, Delayed Graft Function (650 participants)](/report/clinicaltrialstartpulse/hospital-universitario-ramon-y-cajal-nonus--nct-nct07905963)
- [Il-Yang Pharm. Co., Ltd.: Phase 3 study in Benign Prostatic Hyperplasia (660 participants)](/report/clinicaltrialstartpulse/il-yang-pharm-co-ltd-nonus--nct-nct07870759)
- [Imperial College London: Observational study in Multiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting (2000 participants)](/report/clinicaltrialstartpulse/imperial-college-london-nonus--nct-nct07899502)
- [Implicity: Observational study in Cardiovascular Diseases (CVD), Cardiac Implantable Electronic Device (CIED) (100000 participants)](/report/clinicaltrialstartpulse/implicity-nonus--nct-nct07881250)
- [Inha University Hospital: Observational study in Cardiovascular Diseases, Coronary Artery Disease (10000 participants)](/report/clinicaltrialstartpulse/inha-university-hospital-nonus--nct-nct07856472)
- [Inha University Hospital: Observational study in Tachycardia, Paroxysmal Supraventricular Tachycardia (10000 participants)](/report/clinicaltrialstartpulse/inha-university-hospital-nonus--nct-nct07859020)
- [Innovent Biologics (Suzhou) Co. Ltd.: Phase 1 study in Solid Tumors (604 participants)](/report/clinicaltrialstartpulse/innovent-biologics-suzhou-co-ltd-nonus--nct-nct07902804)
- [Innovent Biologics (Suzhou) Co. Ltd.: Phase 3 study started recruiting, 520 planned (Atopic Dermatitis)](/report/clinicaltrialstartpulse/innovent-biologics-suzhou-co-ltd-nonus--nct-nct07754786-recruiting)
- [Institut Cancerologie de l'Ouest: Observational study in Breast Cancer (312 participants)](/report/clinicaltrialstartpulse/institut-cancerologie-de-l-ouest-nonus--nct-nct07888881)
- [Institut National de la Santé Et de la Recherche Médicale, France: Not applicable (device, behavioral) study in Long COVID Syndrome (618 participants)](/report/clinicaltrialstartpulse/institut-national-de-la-sante-et-de-la-recherche-medicale-nonus--nct-nct07909551)
- [Institut National de la Santé Et de la Recherche Médicale, France: Not applicable (device, behavioral) study in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder (500 participants)](/report/clinicaltrialstartpulse/institut-national-de-la-sante-et-de-la-recherche-medicale-nonus--nct-nct07902479)
- [Institute of Cancer Research, United Kingdom: Observational study closed enrollment, 3500 enrolled (Prostate Cancer, BRCA Mutation)](/report/clinicaltrialstartpulse/institute-of-cancer-research-united-kingdom-nonus--nct-nct00261456-enrollment)
- [Institute of Medical Biology, Chinese Academy of Medical Sciences: Phase 2 study in Diphtheria, Pertussis (380 participants)](/report/clinicaltrialstartpulse/institute-of-medical-biology-chinese-academy-of-medical-nonus--nct-nct07891104)
- [Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz: Not applicable (device, behavioral) study in Depressive Disorder, Major Depressive Disorder, Suicidal Ideation (525 participants)](/report/clinicaltrialstartpulse/instituto-de-investigacion-sanitaria-de-la-fundacion-nonus--nct-nct07885722)
- [Instituto de Investigación Sanitaria Gregorio Marañón: Observational study completed, 1718 enrolled (Bloodstream Infection, Pneumonia - Bacterial)](/report/clinicaltrialstartpulse/instituto-de-investigacion-sanitaria-gregorio-maranon-nonus--nct-nct07593547-completed)
- [International AIDS Vaccine Initiative: Phase 2 study closed enrollment, 5531 enrolled (Tuberculosis (TB))](/report/clinicaltrialstartpulse/international-aids-vaccine-initiative-nonus--nct-nct06272812-enrollment)
- [International Centre for Diarrhoeal Disease Research, Bangladesh: Not applicable (device, behavioral) study in Depression, Anxiety (1200 participants)](/report/clinicaltrialstartpulse/international-centre-for-diarrhoeal-disease-research-nonus--nct-nct07890896)
- [IRCCS Sacro Cuore Don Calabria di Negrar: Not applicable (device, behavioral) study in Strongyloides Stercoralis Infection, Device Performance (780 participants)](/report/clinicaltrialstartpulse/irccs-sacro-cuore-don-calabria-di-negrar-nonus--nct-nct07876622)
- [Istituto Scientifico Italiano Colonna Vertebrale: Observational study in Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis (AIS) (30000 participants)](/report/clinicaltrialstartpulse/istituto-scientifico-italiano-colonna-vertebrale-nonus--nct-nct07873554)
- [iVascular S.L.U.: Observational study in PCI Patients, de Novo Coronary Lesions (5000 participants)](/report/clinicaltrialstartpulse/ivascular-s-l-u-nonus--nct-nct07887230)
- [IWK Health Centre: Not applicable (device, behavioral) study in Developmental Disabilities, Psychological Wellbeing (500 participants)](/report/clinicaltrialstartpulse/iwk-health-centre-nonus--nct-nct07869251)
- [Izmir Katip Celebi University: Observational study in Acute Kidney Injury (324 participants)](/report/clinicaltrialstartpulse/izmir-katip-celebi-university-nonus--nct-nct07863505)
- [Janssen Korea, Ltd., Korea: Observational study in Pulmonary Arterial Hypertension (333 participants)](/report/clinicaltrialstartpulse/janssen-korea-ltd-korea-nonus--nct-nct07890285)
- [Janssen Pharmaceutica N.V., Belgium: Observational study closed enrollment, 1314 enrolled (Arthritis, Psoriatic)](/report/clinicaltrialstartpulse/janssen-pharmaceutica-n-v-belgium-nonus--nct-nct05049798-enrollment)
- [Janssen Research & Development, LLC: Phase 3 study in Multiple Myeloma (1000 participants)](/report/clinicaltrialstartpulse/janssen-research-and-development-llc-nonus--nct-nct07903272)
- [Jean-Michel HASCOET: Observational study completed, 1137 enrolled (Bronchiolitis)](/report/clinicaltrialstartpulse/jean-michel-hascoet-nonus--nct-nct07251972-completed)
- [Jeil Pharmaceutical Co., Ltd.: Observational study in Erosive Gastroesophageal Reflux Disease (3000 participants)](/report/clinicaltrialstartpulse/jeil-pharmaceutical-co-ltd-nonus--nct-nct07894939)
- [Jena University Hospital: Observational study in Breast Cancer (750 participants)](/report/clinicaltrialstartpulse/jena-university-hospital-nonus--nct-nct07881679)
- [Ji-Yeob Choi: Not applicable (device, behavioral) study in Prediabetes, Dietary Self-Management (860 participants)](/report/clinicaltrialstartpulse/ji-yeob-choi-nonus--nct-nct07890740)
- [Jiangsu Aosaikang Pharmaceutical Co., Ltd.: Phase 3 study in EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (425 participants)](/report/clinicaltrialstartpulse/jiangsu-aosaikang-pharmaceutical-co-ltd-nonus--nct-nct07897188)
- [Jiangsu Famous Medical Technology Co., Ltd.: Not applicable (device, behavioral) study in Colorectal Cancer (1540 participants)](/report/clinicaltrialstartpulse/jiangsu-famous-medical-technology-co-ltd-nonus--nct-nct07854405)
- [Jiangsu Hansoh Pharmaceutical Co., Ltd.: Phase 3 study in Chronic Myeloid Leukemia (408 participants)](/report/clinicaltrialstartpulse/jiangsu-hansoh-pharmaceutical-co-ltd-nonus--nct-nct07885293)
- [Jiangsu Hansoh Pharmaceutical Co., Ltd.: Phase 3 study in SCHIZOPHRENIA 1 (Disorder) (476 participants)](/report/clinicaltrialstartpulse/jiangsu-hansoh-pharmaceutical-co-ltd-nonus--nct-nct07911787)
- [Jiangsu HengRui Medicine Co., Ltd.: Phase 3 study in Breast Cancer (1050 participants)](/report/clinicaltrialstartpulse/jiangsu-hengrui-medicine-co-ltd-nonus--nct-nct07894328)
- [Jiangsu HengRui Medicine Co., Ltd.: Phase 3 study in Diabetes Mellitus, Type 2 (680 participants)](/report/clinicaltrialstartpulse/jiangsu-hengrui-medicine-co-ltd-nonus--nct-nct07913061)
- [Jiangsu HengRui Medicine Co., Ltd.: Phase 3 study started recruiting, 480 planned (Locally Advanced, Recurrent or Metastatic ESCC Patients Who Have Failed Prior PD-1/PD-L1 Inhibitors Combined With Platinum-based Chemotherapy)](/report/clinicaltrialstartpulse/jiangsu-hengrui-medicine-co-ltd-nonus--nct-nct07790380-recruiting)
- [Jiangsu Simcere Pharmaceutical Co., Ltd.: Phase 3 study in Acute Ischemic Stroke AIS (1092 participants)](/report/clinicaltrialstartpulse/jiangsu-simcere-pharmaceutical-co-ltd-nonus--nct-nct07903701)
- [Jiangsu Taizhou People's Hospital: Not applicable (device, behavioral) study in Atrial Fibrillation (AF), Heart Failure (1200 participants)](/report/clinicaltrialstartpulse/jiangsu-taizhou-people-s-hospital-nonus--nct-nct07896863)
- [Jiangsu Taizhou People's Hospital: Not applicable (device, behavioral) study in Heart Failure (2532 participants)](/report/clinicaltrialstartpulse/jiangsu-taizhou-people-s-hospital-nonus--nct-nct07885488)
- [Jiangxi University of Traditional Chinese Medicine: Observational study completed, 731 enrolled (Type 2 Diabetes)](/report/clinicaltrialstartpulse/jiangxi-university-of-traditional-chinese-medicine-nonus--nct-nct07079085-completed)
- [Jiankuan (Suzhou) Biotechnology Company Limited: Phase 3 study in Rheumatoid Arthrits (590 participants)](/report/clinicaltrialstartpulse/jiankuan-suzhou-biotechnology-company-limited-nonus--nct-nct07856511)
- [Jinling Hospital, China: Observational study in Brown Adipose Tissue, Human (500 participants)](/report/clinicaltrialstartpulse/jinling-hospital-china-nonus--nct-nct07908719)
- [Johannes Gutenberg University Mainz: Observational study in Airway Assessment (2000 participants)](/report/clinicaltrialstartpulse/johannes-gutenberg-university-mainz-nonus--nct-nct07886060)
- [Johns Hopkins Bloomberg School of Public Health: Phase 3 study started recruiting, 3000 planned (Neurodevelopment Outcome, Linear Growth)](/report/clinicaltrialstartpulse/johns-hopkins-bloomberg-school-of-public-health-nonus--nct-nct07695883-recruiting)
- [Kanuni Sultan Suleyman Training and Research Hospital: Observational study in Postoperative Care (480 participants)](/report/clinicaltrialstartpulse/kanuni-sultan-suleyman-training-and-research-hospital-nonus--nct-nct07856537)
- [Kaohsiung Medical University: Observational study in Heart Failure, Fatigue Severity Scale (400 participants)](/report/clinicaltrialstartpulse/kaohsiung-medical-university-nonus--nct-nct07886580)
- [Karabuk University: Observational study in Outcome Measurement, Physiotherapy and Rehabilitation (384 participants)](/report/clinicaltrialstartpulse/karabuk-university-nonus--nct-nct07899580)
- [Kazakh Association of Internal Medicine Specialists: Observational study in Metabolic Dysfunction-Associated Steatotic Liver Disease (420 participants)](/report/clinicaltrialstartpulse/kazakh-association-of-internal-medicine-specialists-nonus--nct-nct07889999)
- [Keymed Biosciences Co.Ltd: Phase 3 study in Multiple Myeloma (MM) (320 participants)](/report/clinicaltrialstartpulse/keymed-biosciences-co-ltd-nonus--nct-nct07910903)
- [Khoja Akhmet Yassawi International Kazakh-Turkish University: Not applicable (device, behavioral) study in Acute Respiratory Diseases (400 participants)](/report/clinicaltrialstartpulse/khoja-akhmet-yassawi-international-kazakh-turkish-nonus--nct-nct07899749)
- [King's College London: Observational study completed, 1020 enrolled (Pregnancy, Antenatal Depression)](/report/clinicaltrialstartpulse/king-s-college-london-nonus--nct-nct06578845-completed)
- [Kite, A Gilead Company: Phase 3 study in Newly Diagnosed Multiple Myeloma (600 participants)](/report/clinicaltrialstartpulse/kite-a-gilead-company-nonus--nct-nct07887672)
- [Kite, A Gilead Company: Phase 3 study in Newly Diagnosed Multiple Myeloma (750 participants)](/report/clinicaltrialstartpulse/kite-a-gilead-company-nonus--nct-nct07903506)
- [Kocaeli City Hospital: Observational study in Acute Respiratory Failure, Critical Illness (1250 participants)](/report/clinicaltrialstartpulse/kocaeli-city-hospital-nonus--nct-nct07909226)
- [Kocaeli City Hospital: Observational study in Blood Transfusion (950 participants)](/report/clinicaltrialstartpulse/kocaeli-city-hospital-nonus--nct-nct07875114)
- [Konkuk University Medical Center: Not applicable (device, behavioral) study completed, 764 enrolled (Heart Diseases, Vascular Diseases)](/report/clinicaltrialstartpulse/konkuk-university-medical-center-nonus--nct-nct05806346-completed)
- [Konstantopoulio-Patission General Hospital of Nea Ionia: Not applicable (device, behavioral) study in Patients Undergoing Gastrointestinal Endoscopy (1300 participants)](/report/clinicaltrialstartpulse/konstantopoulio-patission-general-hospital-of-nea-ionia-nonus--nct-nct07903545)
- [Korea University Anam Hospital: Phase 4 study closed enrollment, 410 enrolled (Coronary Artery Disease, Atherosclerosis of Coronary Artery)](/report/clinicaltrialstartpulse/korea-university-anam-hospital-nonus--nct-nct06767345-enrollment)
- [Kuban State Medical University: Observational study in Internal Carotid Artery Dolichoarteriopathy, Carotid Artery Tortuosity (560 participants)](/report/clinicaltrialstartpulse/kuban-state-medical-university-nonus--nct-nct07882875)
- [Kutahya Health Sciences University: Observational study in Artificial Intelligence, Phlebitis After Infusion (461 participants)](/report/clinicaltrialstartpulse/kutahya-health-sciences-university-nonus--nct-nct07889895)
- [Lady Reading Hospital, Pakistan: Not applicable (device, behavioral) study in Severe Preeclampsia (434 participants)](/report/clinicaltrialstartpulse/lady-reading-hospital-pakistan-nonus--nct-nct07861685)
- [Laval University: Not applicable (device, behavioral) study in Cardiovascular (CV) Risk, Metabolic Health (500 participants)](/report/clinicaltrialstartpulse/laval-university-nonus--nct-nct07869069)
- [Leiden University Medical Center: Not applicable (device, behavioral) study in Liver Disease (Alcoholic or Not), Transplantation (752 participants)](/report/clinicaltrialstartpulse/leiden-university-medical-center-nonus--nct-nct07899853)
- [Linnaeus University: Not applicable (device, behavioral) study in Multimorbidity, Integrated Care (1200 participants)](/report/clinicaltrialstartpulse/linnaeus-university-nonus--nct-nct07899723)
- [Liverpool Heart and Chest Hospital NHS Foundation Trust: Observational study started recruiting, 1200 planned (Asthma (Diagnosis), COPD (Chronic Obstructive Pulmonary Disease))](/report/clinicaltrialstartpulse/liverpool-heart-and-chest-hospital-nhs-foundation-trust-nonus--nct-nct07253883-recruiting)
- [Liverpool John Moores University: Observational study completed, 790 enrolled (Exertional Heat Illness)](/report/clinicaltrialstartpulse/liverpool-john-moores-university-nonus--nct-nct04979455-completed)
- [Liverpool School of Tropical Medicine: Not applicable (device, behavioral) study completed, 600 enrolled (Severe Malaria, Severe Anemia)](/report/clinicaltrialstartpulse/liverpool-school-of-tropical-medicine-nonus--nct-nct06624631-completed)
- [LMC Diabetes & Endocrinology Ltd.: Observational study completed, 3392 enrolled (Diabetes (DM), Type 2 Diabetes)](/report/clinicaltrialstartpulse/lmc-diabetes-and-endocrinology-ltd-nonus--nct-nct07424430-completed)
- [LMC Diabetes & Endocrinology Ltd.: Observational study in Obesity, Type 2 Diabetes (T2D) (650 participants)](/report/clinicaltrialstartpulse/lmc-diabetes-and-endocrinology-ltd-nonus--nct-nct07889453)
- [London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's: Observational study in Alzheimer's Disease (AD), Cognitive Impairment (1000 participants)](/report/clinicaltrialstartpulse/london-health-sciences-centre-research-institute-or-lawson-nonus--nct-nct07912736)
- [LuciLab: Phase 3 study completed, 368 enrolled (Risk Behavior, Cognitive Decline)](/report/clinicaltrialstartpulse/lucilab-nonus--nct-nct06748625-completed)
- [Mabsoft Therapeutics (Shanghai) Co., Ltd.: Phase 1 study started recruiting, 420 planned (Neoplams)](/report/clinicaltrialstartpulse/mabsoft-therapeutics-shanghai-co-ltd-nonus--nct-nct07644650-recruiting)
- [Macfarlane Burnet Institute for Medical Research and Public Health Ltd: Not applicable (device, behavioral) study in Malaria (4350 participants)](/report/clinicaltrialstartpulse/macfarlane-burnet-institute-for-medical-research-and-public-nonus--nct-nct07912528)
- [Mälardalen University: Observational study in Knee Osteoarthritis, Physical Activity Behaviour (500 participants)](/report/clinicaltrialstartpulse/malardalen-university-nonus--nct-nct07875647)
- [Manchester University NHS Foundation Trust: Phase 4 study completed, 657 enrolled (Liver Cirrhosis, Hepatocellular Carcinoma)](/report/clinicaltrialstartpulse/manchester-university-nhs-foundation-trust-nonus--nct-nct05971108-completed)
- [Mansoura University: Not applicable (device, behavioral) study in Web Based Intervention (340 participants)](/report/clinicaltrialstartpulse/mansoura-university-nonus--nct-nct07857278)
- [Mardin Artuklu University: Observational study in Musculoskeletal Discomfort, Ergonomic Risk Perception (323 participants)](/report/clinicaltrialstartpulse/mardin-artuklu-university-nonus--nct-nct07873567)
- [Masaryk University: Observational study in Familial Hypercholesterolaemia (6276 participants)](/report/clinicaltrialstartpulse/masaryk-university-nonus--nct-nct07912281)
- [Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.: Not applicable (device, behavioral) study in Perioperative Hypothermia, Inadvertent Perioperative Hypothermia (680 participants)](/report/clinicaltrialstartpulse/masarykova-nemocnice-v-usti-nad-labem-krajska-zdravotni-a-s-nonus--nct-nct07909252)
- [McGill University Health Centre/Research Institute of the McGill University Health Centre: Phase 3 study in Pneumocystis Jirovecii Pneumonia (416 participants)](/report/clinicaltrialstartpulse/mcgill-university-health-centre-research-institute-of-the-nonus--nct-nct07900373)
- [McMaster University: Not applicable (device, behavioral) study in Guideline Development (741 participants)](/report/clinicaltrialstartpulse/mcmaster-university-nonus--nct-nct07854548)
- [Medical University Innsbruck: Observational study in Sedation Complication, Sedation During GI Endoscopy (500 participants)](/report/clinicaltrialstartpulse/medical-university-innsbruck-nonus--nct-nct07872657)
- [Medical University of Bialystok: Observational study in Decompression Sickness, Barotrauma (384 participants)](/report/clinicaltrialstartpulse/medical-university-of-bialystok-nonus--nct-nct07855861)
- [Medical University of Graz: Not applicable (device, behavioral) study in Atrial Fibrillation (AF) (1500 participants)](/report/clinicaltrialstartpulse/medical-university-of-graz-nonus--nct-nct07899788)
- [Medical University of Vienna: Observational study in Steatotic Liver Disease (20000 participants)](/report/clinicaltrialstartpulse/medical-university-of-vienna-nonus--nct-nct07914582)
- [Medicaweb, S.A.C.V.: Observational study in Cardiovascular Risk Factors, Cardiovascular Diseases (3000 participants)](/report/clinicaltrialstartpulse/medicaweb-s-a-c-v-nonus--nct-nct07863674)
- [Medicines Development for Global Health: Phase 3 study started recruiting, 5100 planned (Lymphatic Filariasis, Scabies)](/report/clinicaltrialstartpulse/medicines-development-for-global-health-nonus--nct-nct07159373-recruiting)
- [MedPacto, Inc.: Observational study in High-Grade Osteosarcoma (400 participants)](/report/clinicaltrialstartpulse/medpacto-inc-nonus--nct-nct07878364)
- [Meir Medical Center: Observational study in Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest Patients (2000 participants)](/report/clinicaltrialstartpulse/meir-medical-center-nonus--nct-nct07899645)
- [Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital: Not applicable (device, behavioral) study closed enrollment, 363 enrolled (Self-Injurious Behavior)](/report/clinicaltrialstartpulse/mental-health-centre-copenhagen-bispebjerg-and-nonus--nct-nct05179655-enrollment)
- [Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany: Observational study closed enrollment, 366 enrolled (Multiple Sclerosis)](/report/clinicaltrialstartpulse/merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-nonus--nct-nct05797740-enrollment)
- [Merck Sharp & Dohme LLC: Phase 1 study completed, 330 enrolled (Healthy)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-nonus--nct-nct07405177-completed)
- [Merck Sharp & Dohme LLC: Phase 1 study in Lower Respiratory Tract Infection (564 participants)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-nonus--nct-nct07855510)
- [Merck Sharp & Dohme LLC: Phase 2 study in Pain Management (380 participants)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-nonus--nct-nct07862595)
- [Merck Sharp & Dohme LLC: Phase 3 study in Pulmonary Disease, Chronic Obstructive (2136 participants)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-nonus--nct-nct07874815)
- [Merck Sharp & Dohme LLC: Phase 3 study in Small Cell Lung Cancer (564 participants)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-nonus--nct-nct07908537)
- [Merck Sharp & Dohme LLC: Phase 3 study started recruiting, 930 planned (Papillomavirus Infections)](/report/clinicaltrialstartpulse/merck-sharp-and-dohme-llc-nonus--nct-nct07785843-recruiting)
- [Minia University: Observational study in Difficult Airway Management (550 participants)](/report/clinicaltrialstartpulse/minia-university-nonus--nct-nct07887503)
- [Molde University College: Not applicable (device, behavioral) study in Health Literacy, Occupational Health (480 participants)](/report/clinicaltrialstartpulse/molde-university-college-nonus--nct-nct07878403)
- [Mundipharma (China) Pharmaceutical Co. Ltd: Observational study in Cancer Pain (378 participants)](/report/clinicaltrialstartpulse/mundipharma-china-pharmaceutical-co-ltd-nonus--nct-nct07869797)
- [Nagasaki University: Observational study in Tuberculosis, Extrapulmonary Tuberculosis (700 participants)](/report/clinicaltrialstartpulse/nagasaki-university-nonus--nct-nct07901387)
- [Nanfang Hospital, Southern Medical University: Observational study in Cataract, Primary Angle-Closure Glaucoma (500 participants)](/report/clinicaltrialstartpulse/nanfang-hospital-southern-medical-university-nonus--nct-nct07903454)
- [Nanfang Hospital, Southern Medical University: Observational study in Musculoskeletal Growth and Development (500 participants)](/report/clinicaltrialstartpulse/nanfang-hospital-southern-medical-university-nonus--nct-nct07857798)
- [Nanjing First Hospital, Nanjing Medical University: Not applicable (device, behavioral) study in Delirium - Postoperative (600 participants)](/report/clinicaltrialstartpulse/nanjing-first-hospital-nanjing-medical-university-nonus--nct-nct07908121)
- [Nanjing First Hospital, Nanjing Medical University: Observational study in Colorectal Adenoma, Cholecystectomy (8450 participants)](/report/clinicaltrialstartpulse/nanjing-first-hospital-nanjing-medical-university-nonus--nct-nct07908576)
- [Nanjing First Hospital, Nanjing Medical University: Phase 3 study in Helicobacter Infection (612 participants)](/report/clinicaltrialstartpulse/nanjing-first-hospital-nanjing-medical-university-nonus--nct-nct07904429)
- [Nanjing Leads Biolabs Co.,Ltd: Phase 2 study started recruiting, 369 planned (Metastatic Colorectal Carcinoma)](/report/clinicaltrialstartpulse/nanjing-leads-biolabs-co-ltd-nonus--nct-nct07791758-recruiting)
- [Nanjing Medical University: Observational study in Prediabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) (30000 participants)](/report/clinicaltrialstartpulse/nanjing-medical-university-nonus--nct-nct07854002)
- [Nantes University Hospital: Not applicable (device, behavioral) study in Uterine Polyps, Uterine Fibroids (474 participants)](/report/clinicaltrialstartpulse/nantes-university-hospital-nonus--nct-nct07908615)
- [Nantes University Hospital: Observational study in Bacteremia (8765 participants)](/report/clinicaltrialstartpulse/nantes-university-hospital-nonus--nct-nct07894237)
- [National and Kapodistrian University of Athens: Observational study in Colorectal Diseases, Anal Diseases (400 participants)](/report/clinicaltrialstartpulse/national-and-kapodistrian-university-of-athens-nonus--nct-nct07874412)
- [National Cancer Center, Korea: Not applicable (device, behavioral) study in Advanced Solid Tumors, Metastatic Solid Tumors (2800 participants)](/report/clinicaltrialstartpulse/national-cancer-center-korea-nonus--nct-nct07891169)
- [National Cancer Centre, Singapore: Not applicable (device, behavioral) study in Colorectal Cancer (40000 participants)](/report/clinicaltrialstartpulse/national-cancer-centre-singapore-nonus--nct-nct07852793)
- [National Institute of Allergy and Infectious Diseases (NIAID): Phase 3 study closed enrollment, 5832 enrolled (Tuberculosis, MDR)](/report/clinicaltrialstartpulse/national-institute-of-allergy-and-infectious-diseases-niaid-nonus--nct-nct03568383-enrollment)
- [National Institute of Allergy and Infectious Diseases (NIAID): Phase 3 study in Sexually Transmitted Infection (STI), Gonorrhea (580 participants)](/report/clinicaltrialstartpulse/national-institute-of-allergy-and-infectious-diseases-niaid-nonus--nct-nct07884240)
- [National Institute of Public Health, Clinical Epidemiology, and Toxicology-Lebanon (INSPECT-LB): Not applicable (device, behavioral) study in Older Adults (65 Years and Older), Polypharmacy (People Under Treatment With 5 or More Drugs) (452 participants)](/report/clinicaltrialstartpulse/national-institute-of-public-health-clinical-epidemiology-nonus--nct-nct07866677)
- [National Sun Yat-sen University: Observational study in OSA - Obstructive Sleep Apnea, Dysphagia (450 participants)](/report/clinicaltrialstartpulse/national-sun-yat-sen-university-nonus--nct-nct07880067)
- [National Taiwan University Hospital: Not applicable (device, behavioral) study in Emergency Department, Revisit (4010 participants)](/report/clinicaltrialstartpulse/national-taiwan-university-hospital-nonus--nct-nct07909096)
- [National University Hospital, Singapore: Not applicable (device, behavioral) study in Brain Injuries (1000 participants)](/report/clinicaltrialstartpulse/national-university-hospital-singapore-nonus--nct-nct07904624)
- [National University of Singapore: Not applicable (device, behavioral) study in Focused Strategies to Optimize Sleep, Reduce Sedentary Behaviour, and Enhance Incidental Physical Activity (2000 participants)](/report/clinicaltrialstartpulse/national-university-of-singapore-nonus--nct-nct07887269)
- [New Valley University: Observational study in Medical Education (1000 participants)](/report/clinicaltrialstartpulse/new-valley-university-nonus--nct-nct07912749)
- [Nivi, Inc.: Not applicable (device, behavioral) study in Pregnancy, Prenatal Care (2500 participants)](/report/clinicaltrialstartpulse/nivi-inc-nonus--nct-nct07883993)
- [Norwegian University of Science and Technology: Phase 4 study in Lower Respiratory Tract Infection (LRTI), Recurrent Wheezing (486 participants)](/report/clinicaltrialstartpulse/norwegian-university-of-science-and-technology-nonus--nct-nct07858773)
- [Nova Scotia Health Authority: Not applicable (device, behavioral) study in Mechanical Ventilation, Cardiac Surgery (336 participants)](/report/clinicaltrialstartpulse/nova-scotia-health-authority-nonus--nct-nct07874607)
- [Novo Nordisk A/S: Observational study in Overweight, Obesity (10000 participants)](/report/clinicaltrialstartpulse/novo-nordisk-a-s-nonus--nct-nct07881770)
- [October 6 University: Observational study in Acute Coronary Syndrome (1000 participants)](/report/clinicaltrialstartpulse/october-6-university-nonus--nct-nct07876336)
- [Odense University Hospital: Not applicable (device, behavioral) study in Cardiovascular Disease, Cardiometabolic Diseases (375 participants)](/report/clinicaltrialstartpulse/odense-university-hospital-nonus--nct-nct07878325)
- [Odense University Hospital: Phase 4 study started recruiting, 7000 planned (Ischemic Heart Disease, Ischemic Heart Disease Chronic)](/report/clinicaltrialstartpulse/odense-university-hospital-nonus--nct-nct07795398-recruiting)
- [Onconic Therapeutics Inc.: Phase 3 study in H. Pylori Eradication Therapy (414 participants)](/report/clinicaltrialstartpulse/onconic-therapeutics-inc-nonus--nct-nct07875933)
- [Oslo Metropolitan University: Observational study closed enrollment, 9836 enrolled (The Focus of the Study is Shift Work)](/report/clinicaltrialstartpulse/oslo-metropolitan-university-nonus--nct-nct05784324-enrollment)
- [Oslo University Hospital: Not applicable (device, behavioral) study started recruiting, 500 planned (Alcoholic Liver Disease (ALD), Alcohol Use Disorder)](/report/clinicaltrialstartpulse/oslo-university-hospital-nonus--nct-nct07637539-recruiting)
- [Ottawa Heart Institute Research Corporation: Not applicable (device, behavioral) study closed enrollment, 382 enrolled (Smoking Cessation, Smoking Behaviors)](/report/clinicaltrialstartpulse/ottawa-heart-institute-research-corporation-nonus--nct-nct05799625-enrollment)
- [Ottawa Heart Institute Research Corporation: Not applicable (device, behavioral) study closed enrollment, 390 enrolled (Infection)](/report/clinicaltrialstartpulse/ottawa-heart-institute-research-corporation-nonus--nct-nct04591366-enrollment)
- [Patuakhali Science and Technology University: Not applicable (device, behavioral) study in Iron Deficiency Anaemia Due to Dietary Causes, Folic Acid Deficiency Anemia, Dietary (440 participants)](/report/clinicaltrialstartpulse/patuakhali-science-and-technology-university-nonus--nct-nct07903558)
- [Peking Union Medical College Hospital: Observational study in Glycogen Storage Disease (318 participants)](/report/clinicaltrialstartpulse/peking-union-medical-college-hospital-nonus--nct-nct07908212)

[1](/hub/clinicaltrialstartpulse/records) 2 [3](/hub/clinicaltrialstartpulse/records/3) [4](/hub/clinicaltrialstartpulse/records/4) [5](/hub/clinicaltrialstartpulse/records/5)

[Browse ClinicalTrialStartPulse by category and location](/hub/clinicaltrialstartpulse) · [Search and filter ClinicalTrialStartPulse](/v/clinicaltrialstartpulse)